Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-19-037236

Director bought 500 shares at $1.14 ($570)

From the SEC's structured data for this filing

Trades in this filing

Harsh Michael · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-06-10 Purchase : show line 1 in the form +500 $1.14 $570 10,000 D
Open-market purchases · 500 sh · avg $1.14 · $570
Loading xslF345X03/doc4.xml…